Position in AUPH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,251,450
-$2,466,935 QoQ
Shares Held
191,600
-50.3% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 279 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 66%
Shared 0%
None 34%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Derivatives in AUPH
reported options exposure · as of Mar 31, 2022CallValue
$366,448
CallShares
29,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. AUPH ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in AUPH
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,251,450 | 191,600 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,718,385 | 385,856 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,062,017 | 254,672 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,196,163 | 198,748 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,758,077 | 325,629 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,067,396 | 257,139 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,915,191 | 213,273 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,104,622 | 150,699 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $783,263 | 137,174 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,005,916 | 200,782 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,278,857 | 253,488 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,493,253 | 192,182 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,346,141 | 242,370 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,440,900 | 131,469 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $201,125 | 46,557 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $276,170 | 36,725 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,507,680 | 150,018 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $2,173,519 | 175,567 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $366,448 | 29,600 | Call | Defined | 2022-05-16 | |
| 2021-12-31 | $2,602,285 | 113,786 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $221,300 | 10,000 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $5,260,941 | 237,729 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $340,802 | 15,400 | Call | Defined | 2021-11-15 | |
| 2021-06-30 | $3,372,256 | 260,205 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,308,993 | 254,832 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,988,427 | 216,083 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,494,024 | 169,316 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,653,957 | 101,782 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $1,776,052 | 122,402 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||